Spirus Medical spirusmed.com


Public lists: Medical Devices (6123)

Spirus Medical has developed a new medical device for use in the diagnosis and treatment of gastrointestinal (GI) disorders. Spirus Medical's endoluminal platform technology has indications in other medical applications including urology and gynecology. In July 2011, Spirus Medical was acquired by Olympus Corporation. The valuation of Spirus Medical was $60 million. Other terms of the deal were not released.

Spirus Medical has developed a new medical device for use in the diagnosis and treatment of gastrointestinal (GI) disorders. Spirus Medical's endoluminal platform technology has indications in other medical applications including urology and gynecolo...Show all

Company (Acquired)

Phone: 781-297-7220

Fax:

375 West Street

West Bridgewater, 02379
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Spirus Medical $15M Jul 5, 2011
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Spirus Medical Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors

Competitors

Company Status Description Investors

NeuroPace

Mountain View, California, United States
Alive / ActiveNeuroPace designs, develops, manufactures and markets implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately one percent of the population worldwide. An estimated 30-40 percent of the 50 million people worldwide (including more than 3 million Americans) experience uncontrolled seizures. In addition to treating epilepsy, responsive neuros...Show allLogin to see details

MicroTransponder

Austin, Texas, United States
Alive / ActiveMicroTransponder is developing a wireless neurostimulation system for the treatment of chronic pain and several other neurological indications. The minimally invasive device will provide relief from chronic pain without requiring an implanted battery or wires. The Company is finishing R&D on the device and accumulating data toward FDA clearance. MicroTransponder is also adapting the company's system for Vagus Nerve Stimulation to create a pipeline of treatments for other neurological indications...Show allLogin to see details
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Rotate-to-advance catheterization system May 04, 2005 Mar 22, 2011 Patent
Anatomical model May 21, 2007 Dec 21, 2010 Patent
Rotate to advance catheterization system Jul 26, 2005 Oct 05, 2010 Patent
Rotate-to-advance catheterization system May 19, 2006 Aug 24, 2010 Patent